Medical Technologies

Stryker Completes Acquisition of ZuriMED to Enhance Shoulder Injury Treatment Technologies

Stryker has completed the acquisition of the Swiss company ZuriMED to integrate the advanced FiberLocker system into its technology portfolio, enhancing rotator cuff repair procedures in sports medicine.

2026-10-27
2 min read
15 views
certi.news Editorial Team
Stryker Completes Acquisition of ZuriMED to Enhance Shoulder Injury Treatment Technologies

Stryker has announced the completion of its acquisition of the Swiss company ZuriMED, a strategic move aimed at expanding its range of technical solutions in the field of sports medicine and shoulder injury treatment. Through this transaction, Stryker will add the FiberLocker system to its portfolio, a 510(k)-cleared medical device designed to reinforce the rotator cuff during or after surgical repair procedures.

Technical Mechanism of the FiberLocker System

The FiberLocker system relies on a technology that integrates two primary components to ensure tissue stability:

  • Non-resorbable implant: Made of durable polyester fibers that act as a tissue scaffold.
  • Micro-stapling device: A specialized surgical tool to securely anchor the implant within soft tissue.

This technology provides additional mechanical support that integrates with surgical sutures or traditional bone anchors, helping to hold medical patches in place to promote the healing process.

Why This Development Matters

This technology aims to address a significant medical challenge in shoulder surgery; systematic reviews indicate that the re-tear rate for the rotator cuff reaches 21% within three to six months post-surgery. ZuriMED has already begun human testing of the device, currently conducting a study in Switzerland focused on safety standards, in parallel with a multi-center trial in the United States aimed at evaluating healing efficacy six months after treatment, using magnetic resonance imaging (MRI) to assess outcomes.

Stryker's Strategic Shift

This acquisition represents a shift in Stryker's investment focus; after concentrating over the past two years on acquisitions in the peripheral vascular sector (such as the Inari Medical and Amplitude Vascular deals), the company is now moving strongly toward strengthening its leadership in sports medicine. The integration of technologies like FiberLocker supports integrated technical growth, especially with the commercial launch of the Mako Shoulder system associated with the Mako 4 robot, enhancing the company's ability to provide integrated digital and mechanical surgical solutions for treating shoulder injuries.

News source
c
Author

certi.news Editorial Team

In the same category

You may also like

View all news